Improvements in survival after dialysis in the elderly

NewsGuard 100/100 Score

The majority of patients starting dialysis as a result of chronic kidney disease are 65 years or older at the time of their first treatment, and many are over 75 years.

Dr. Sarbjit Vanita Jassal and colleagues sought to calculate the mean life-expectancy of patients who began dialysis at either 65–74 years of age or at 75 years or more, and to identify where there was any change in survival probability or in the effect of comorbidities (such as diabetes or heart problems) in this patient population over the decade 1990 to 1999.

In this retrospective cohort study of data from the Canadian Organ Replacement Register, the researchers found that survival among 14 512 elderly patients who began dialysis between 1990 and 1999 improved over time, despite their increasing burden of comorbidity. Specifically, patients aged 65–74 years at the start of dialysis experienced a 23% improvement in survival and those aged 75 or more a 15% improvement. The authors conclude that age alone should not be used as a deterrent to initiating dialysis; rather, the decision should be made on an individual basis and other factors taken into account, including comorbidities, functional abilities and overall quality of life.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events